Ryan Williams: This Article Brings to Light The Complexity of PRP…
Ryan Williams, Physician Assistant at BHS Orthopedic Associates, shared on LinkedIn about a recent article by Benjamin B. Rothrauff et al, published in The American Journal of Sports Medicine:
”This article brings to light the complexity of PRP on more than the most popular topic, platelet dose.
The authors highlight patient specific impact, biologic composition, preparation, activation, ability to store PRP for future use, allogenic vs. autologous PRP, EVs, and peri-procedure optimization.
Practically, variables that can be impacted are:
1. Optimize the patient (address comorbidities, nutrition, exercise, sleep, and stress).
2. Have a consistent, high quality PRP protocol.
3. Use safe, quality, and value-based energy (not mentioned in the article), exercise (BFR), pharmaceutical and nutraceutical tools to enhance the patient and the composition of the PRP.
I’m curious of others real-world experience with pre-blood draw exercise and BFR, using a senolytic (dasatinib and quercetin, fisetin, astragalus/TA-65, etc.) or losartan (or any ARB) and any other optimization strategies.
I’ve had some patients inquire about optimizing their PRP with exercise and supplements.
I’ve had several ask about red/NIR light therapy which I encourage them to do before the procedure and continue after if they have already purchased a device (this was not mentioned in the article). ”
Title: Platelet-Rich Plasma in the Treatment of Musculoskeletal Disease in 2025 and Beyond
Authors: Benjamin B. Rothrauff, Joseph T. Featherall, Tyler J. Uppstrom, Greta Gohring, Anna-Laura Nelson, Thos A. Evans, Peter J. Millett, Matthew T. Provencher, Marc J. Philippon, Johnny Huard
Read the Full Article on The American Journal of Sports Medicine
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?
-
Sep 30, 2026, 13:03Amira Mohy: Diagnostic Flow Cytometry Panels for Hematological Malignancies
-
Sep 30, 2026, 12:52Paul Watton: Could Repetitive Head Impacts Leave a Molecular Memory?
-
Sep 30, 2026, 12:41The Journey to ISTH 2027 Starts in Vancouver
-
Sep 30, 2026, 11:36Basit Ali: A Closer Look at CT Venography